France Parliament to Debate PGT-A Preimplantation Genetic Testing Bill
A cross-party bill to legalize preimplantation genetic diagnosis for aneuploidies in France will face a public session on December 1, 2026.
- The proposed legislation targets preimplantation genetic testing for aneuploidies, known as PGT-A, during in vitro fertilization procedures.
- Proponents state that more than 65,000 embryo transfers fail annually in France, with three out of four resulting in no live birth.
- Political figures including Health Minister Stéphanie Rist have voiced support for lifting the national ban.
PGT-A screening is currently prohibited in France, forcing couples who wish to utilize the chromosomal analysis to seek care in other European countries. The legislation was drafted following a report on declining birth rates.
“It is above all a major advance for women’s health,” Constance de Pélichy, UDI deputy who led the proposal, said.
The procedure examines the chromosome count of an embryo prior to uterine transfer during assisted reproductive technology treatments. Identifying chromosomal abnormalities aims to reduce the incidence of pregnancy losses, failed implantation, and developmental complications.
“Behind these figures, women are chaining hormone injections, punctures, miscarriages, and sometimes medical terminations of pregnancy,” de Pélichy said, describing the physical and psychological toll of infertility.
Supporters of the measure argue that updating the legislative framework will align French medical practice with technological capabilities that can prevent repetitive pregnancy failures.
Political momentum behind the measure crosses party lines. Marine Tondelier, an ecologist candidate for the 2027 presidential election, has publicly supported the authorization after previously traveling abroad for the procedure.
Health Minister Stéphanie Rist has also expressed favor for the bill as it heads toward the National Assembly.
The public debate is scheduled to open on December 1, 2026, when parliamentarians will review the proposed removal of the current ban.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice.